These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1257736)

  • 1. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trasicor versus methyldopa in Pakistani hypertensive patients: a comparative study of efficacy and tolerability.
    Nasir ; Burke T
    J Pak Med Assoc; 1981 Aug; 31(8):172-7. PubMed ID: 6793746
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxprenolol and hydrallazine in the treatment of hypertension.
    Freeman JW; Knight LW
    Med J Aust; 1975 Jan; 1(SP2):12-3. PubMed ID: 1124019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice.
    Forrest WA
    J Int Med Res; 1979; 7(4):318-23. PubMed ID: 488521
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
    Fidler J; Smith V; Fayers P; De Swiet M
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1927-30. PubMed ID: 6407638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxprenolol, methyldopa and lipids in diabetes mellitus.
    Benfield GF; Hunter KR
    Br J Clin Pharmacol; 1982 Feb; 13(2):219-22. PubMed ID: 7037030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
    Levenstein JH
    S Afr Med J; 1979 Apr; 55(17):656. PubMed ID: 462285
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
    Forrest WA
    J Int Med Res; 1978; 6(2):136-40. PubMed ID: 631415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
    Gallery ED; Ross MR; Gyory AZ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):563-6. PubMed ID: 3929874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily administration of a beta-blocker in hypertension.
    Watt M; Duncan TD
    N Z Med J; 1978 Feb; 87(606):126-8. PubMed ID: 274648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
    Gallery ED; Saunders DM; Hunyor SN; Györy AZ
    Br Med J; 1979 Jun; 1(6178):1591-4. PubMed ID: 466138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: General practitioner studies of beta-blockade in hypertension.
    Forrest WA
    Scott Med J; 1974 Jan; 19(1):49-50. PubMed ID: 4150628
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.